Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FK 3311

Known as: FK-3311, FK3311 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Purpose: Our objective was to evaluate whether COX-2 inhibition with FK3311, a selective cyclooxygenase (COX)-2 inhibitor… Expand
Is this relevant?
2007
2007
BACKGROUND/AIMS This study was designed to investigate the effects of a selective cyclooxygenase-2 inhibitor, FK3311, on warm… Expand
Is this relevant?
2007
2007
Ischemia–reperfusion injury is induced by activation of the arachidonic acid cascade following the induction of cyclooxygenase-2… Expand
Is this relevant?
2006
2006
BACKGROUND Cyclooxygenase (COX) is an intracellular enzyme that converts arachidonic acid to prostaglandin endoperoxide (PGG(2… Expand
Is this relevant?
2003
2003
BACKGROUND/AIMS The purpose of this study was to investigate the effects of a selective COX-2 inhibitor, FK3311, on warm ischemia… Expand
Is this relevant?
2001
2001
BACKGROUND Liver grafts from non-heart-beating donors inevitably suffer from warm ischemic injury. In these grafts, large… Expand
Is this relevant?
2001
2001
BACKGROUND This study investigated the effects of a selective COX-2 inhibitor, FK3311, on warm ischemia-reperfusion (I/R) injury… Expand
Is this relevant?
2001
2001
BACKGROUND In the process of ischemia-reperfusion, inflammatory cytokines and arachidonic acid metabolites are released and… Expand
Is this relevant?
2000
2000
T614 (3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne) is a member of the family of methanesulfonanilide non… Expand
Is this relevant?